Results for tag: "Omacetaxine Mepesuccinate"

Omacetaxine Mepesuccinate is an oncology drug used to treat chronic myeloid leukemia (CML). It is a protein synthesis inhibitor that works by blocking the activity of an enzyme called tyrosine kinase, which is involved in the growth and spread of cancer cells. It is administered as a subcutaneous injection and is available in both capsule and solution form. Omacetaxine Mepesuccinate is approved by the US Food and Drug Administration (FDA) for the treatment of CML in adults who have failed to respond to other therapies. It is also approved for use in combination with other drugs for the treatment of CML in adults who have failed to respond to other therapies. The market for Omacetaxine Mepesuccinate is highly competitive, with several companies offering the drug. Some of the major players in the market include Novartis, Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more